Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer


NCT01910610

Interventional

Phase 3

Recruiting
STRATEGIC-1
STRATEGIC-1 is a study designed to determine the best sequence of therapy in patients with metastatic colorectal cancer.
Jul 31,2013
All
18 Years
N/A
474

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.